FOR IMMEDIATE RELEASE:
Singapore (December 26, 2008) – Clearstate Pte. Ltd. and Medtech Insight announce the signing of adistribution and revenue sharing agreement to initiate what promises to be an exciting long term mutually productive relationship. This deal will help bring Clearstate into a position to sell its advisory and database products to a wider range of customers across the globe and gives Medtech Insight a reliable and committed partner to provide Asia Pacific market research reports to complement their extensive North American and European product lines.
Medtech Insight is known in the Life Sciences industry for their range of Market and Technology Reports in areas that include Cardiovascular Therapeutics and Diagnostics, Interventional Radiology and Vascular Procedures, Orthopedics and Musculoskeletal, Surgical Markets, Wound Management, and a wide range of other therapeutic and diagnostic markets. “We are very excited to work with Clearstate,” said Neil Smith, Director, Medical Device Reports with Medtech Insight. “Teaming up with Clearstate to provide Asia Pacific market research is an exciting development for our company and will enable us to provide the most comprehensive analyses of the devices, technologies, procedures, and companies shaping the global medical technology market.”
“Medtech Insight is an established well respected company within the Life Sciences intelligence space and this agreement reflects our desire to collaborate with companies that share our vision and underscores our commitment to provide Life Sciences clients with the highest quality comprehensive and actionable market intelligence especially as it pertains to the relatively opaque Asia Pacific markets”, said Tej Deol M.D. Managing Partner, Clearstate.
About Clearstate Pte. Ltd.
Founded in 2006 and headquartered in Singapore, Clearstate, a niche healthcare consultancy, offers strategic advisory and intelligence services to help medical devices, healthcare services, pharmaceutical and biotechnology firms understand their current and potential markets, implement pragmatic and innovative strategies to ultimately tap into new growth opportunities. Our approach to engagements is centred on thorough analysis of fact-based intelligence and seasoned understanding of markets, practical strategy recommendations and implementations.
We provide accurate, reliable and comprehensive intelligence on medical device usage and demand across Asia Pacific. We deliver actual and up-to-date placement, usage and consumption data for devices, equipment and consumables found in healthcare and commercial settings. For more information about Clearstate, visit its website at http://www.clearstate.com.
About Medtech Insight
Medtech Insight, a division of Elsevier Business Intelligence (formerly FDC-Windhover), provides the medical device and healthcare investment industries with consistent, comprehensive and meticulously researched market analyses that incorporate strategic vision and a thorough understanding of competing technologies. For more on the company’s products, services and investment and partnering events, please visit www.medtechinsight.com